VESTAL POINT CAPITAL, LP

Adviser information for VESTAL POINT CAPITAL, LP last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 10
Investment Advisory/Research 7
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 4 $1.8B
Non-Discretionary 0 $0
Total 4 $1.8B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 3 $736.3M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other <5 $1.1B
Type Number
No. of Non-RAUM Clients 4
No. of Non-U.S. Clients 75

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-127682
SEC ERA File Number 801-127682
SEC CIK Numbers 1974915
SEC CRD Numbers 325894
Legal Entity Identifier 5493000BKRWNKB4XNM02

Principal Office

632 BROADWAY
SUITE 602
NEW YORK
NY
United States
Monday - Friday, 8AM-5PM
Tel: 646-989-4000, Fax: None

Chief Compliance Officer

ILKO MENKOV
PARTNER & COO
632 BROADWAY
SUITE 602
NEW YORK
NY
United States
Tel: 646-989-4000
(Full email address available in API data)

Industry Affiliates

VESTAL POINT PARTNERS GP, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
VESTAL POINT MASTER FUND, LP Hedge Fund $736.3M $1.0M 33

Control Persons

Name Type Entity Title Since Ownership
WILDER, RYAN, CHRISTOPHER Individual MANAGING PARTNER AND CHIEF INVESTMENT OFFICER 04/2023 > 75%
MENKOV, ILKO, LATCHEZAROV Individual PARTNER, COO AND CCO 04/2023 5-10%

No. Employees, Historic

10502023202420256 on 3/17/20239 on 8/10/202310 on 3/27/2024

RAUM, Historic

2B1B02023202420251273044872 on 8/10/20231841931516 on 3/27/2024

No. Clients, Historic

10502023202420253 on 3/17/20233 on 8/10/20233 on 3/27/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
Achilles Therapeutics PLC SPONSORED ADS 1M 2M
Allogene Therapeutics Inc COM 5M 2M
Alto Neuroscience Inc COM SHS 7M 620K
ALX Oncology Holdings Inc COM 22M 4M
Apellis Pharmaceuticals Inc COM 13M 335K
Applied Therapeutics Inc COM 25M 5M
Arcellx Inc COMMON STOCK 37M 675K
Ascendis Pharma A/S SPONSORED ADR 102M 750K
Astria Therapeutics Inc COM 30M 3M
Atara Biotherapeutics Inc COM NEW 952K 112K
Axsome Therapeutics Inc COM 24M 300K
BeiGene Ltd SPONSORED ADR 50M 350K
BioNTech SE SPONSORED ADS 8M 100K
Black Diamond Therapeutics Inc COM 10M 2M
Bristol-Myers Squibb Co COM 21M 500K
Chimerix Inc COM 1M 1M
Cytokinetics Inc COM NEW 112M 2M
Day One Biopharmaceuticals Inc COM 17M 1M
Denali Therapeutics Inc COM 12M 500K
Dianthus Therapeutics Inc COM 16M 600K
Dyne Therapeutics Inc COM 8M 225K
Exact Sciences Corp COM 39M 925K
Fate Therapeutics Inc COM 7M 2M
Fulcrum Therapeutics Inc COM 7M 1M
Galapagos NV SPON ADR 4M 180K
Globus Medical Inc CL A 62M 900K
Immatics NV SHS 32M 3M
Immunome Inc COM 12M 1M
Inari Medical Inc COM 17M 350K
Insmed Inc COM PAR $.01 50M 750K
Inspire Medical Systems Inc COM 8M 60K
Iovance Biotherapeutics Inc COM 2M 300K
iTeos Therapeutics Inc COM 26M 2M
Janux Therapeutics Inc COM 30M 725K
Jazz Pharmaceuticals PLC SHS USD 160M 2M
KalVista Pharmaceuticals Inc COM 27M 2M
Lexeo Therapeutics Inc COM 13M 840K
Liquidia Corp COM NEW 22M 2M
MacroGenics Inc COM 3M 800K
Monte Rosa Therapeutics Inc COM 3M 890K
Newamsterdam Pharma Co NV ORDINARY SHARES 480K 25K
Nurix Therapeutics Inc COM 10M 500K
Pacira BioSciences Inc COM 8M 280K
Passage Bio Inc COM 5M 6M
Praxis Precision Medicines Inc COM NEW 18M 440K
Prime Medicine Inc COM 2M 450K
PTC Therapeutics Inc COM 3M 90K
Relmada Therapeutics Inc COM 4M 1M
Reneo Pharmaceuticals Inc COM 823K 545K
Savara Inc COM 26M 6M
Soleno Therapeutics Inc COM 49M 1M
Solid Biosciences Inc COM NEW 15M 3M
Structure Therapeutics Inc SPONSORED ADS 22M 560K
Ultragenyx Pharmaceutical Inc COM 74M 2M
uniQure NV SHS 21M 5M
Ventyx Biosciences Inc COM 3M 1M
Verve Therapeutics Inc COM 2M 500K
Voyager Therapeutics Inc COM 5M 600K
Xenon Pharmaceuticals Inc COM 20M 525K
Zymeworks Inc COM 4M 440K